AmblYOtech is where
science meets screen time

As a company that’s part life science and part software development, we are committed to offering revolutionary, first-in-class solutions for treating amblyopia and other ocular disorders.

Amblyotech develops and commercializes novel and clinically proven medical modalities

Leadership

Joseph Koziak Icon

Joseph Koziak, CEO
Joseph’s background over the past 20 years covers the acquisition, development, and commercialization of medical devices, diagnostic products, and pharmaceuticals. He has founded and created successful exit strategies for 3 start-ups. Joseph has raised equity financing and negotiated industry-leading collaboration and licensing agreements with Roche, Novartis, Atrium, and Ubisoft.

Robert Dericotte

Robert Derricotte, COO
Robert Derricotte has 25 years of pharmaceutical and medical device experience in the areas of sales, marketing and business development. Mr. Derricotte has been in leadership and brand management at GD Searle, Pharmacia, UCB Pharma, Ketal Biomedical . Prior to Amblyotech, he has founded several ventures including Georgia Bioscience Commercialization Center and Healthcare First.

SCIENTIFIC ADVISOR

PARTNER

Professor Robert F. Hess icon

Professor Robert F. Hess 
Professor Hess is the Director of Research at the Department of Ophthalmology, McGill University, Canada, and Director of its Vision Research Unit. He is also an associate faculty member of McGill’s Departments of Psychology, Neurology, and Neurosurgery.

Ubisoft Logo Icon

UBISOFT
Ubisoft is a leading creator, publisher, and distributor of interactive entertainment and services, with a rich portfolio of world-renowned brands.

The teams throughout Ubisoft’s worldwide network of studios and business offices are committed to delivering original and memorable gaming experiences across all popular platforms, including consoles, mobile phones, tablets, and PCs. For the 2016-17 fiscal year, Ubisoft generated sales of €1,460 million. To learn more, please visit www.ubisoftgroup.com.

SCIENTIFIC ADVISOR

Professor Robert F. Hess icon

Professor Robert F. Hess 
Professor Hess is the Director of Research at the Department of Ophthalmology, McGill University, Canada, and Director of its Vision Research Unit. He is also an associate faculty member of McGill’s Departments of Psychology, Neurology, and Neurosurgery.

PARTNER

Ubisoft Logo Icon

UBISOFT
Ubisoft is a leading creator, publisher, and distributor of interactive entertainment and services, with a rich portfolio of world-renowned brands.

The teams throughout Ubisoft’s worldwide network of studios and business offices are committed to delivering original and memorable gaming experiences across all popular platforms, including consoles, mobile phones, tablets, and PCs. For the 2016-17 fiscal year, Ubisoft generated sales of €1,460 million. To learn more, please visit www.ubisoftgroup.com.

Site map          Privacy Policy          Contact us

Amblyotech is a registered trademark of Amblyotech, Inc. • All other marks used herein are the property of their respective owners. • ©2017 Amblyotech, Inc. All rights reserved.